EUR RADIOL 2019 10.1007/s00330-019-06239-z
Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation
Kang1, YK; Choi, JY; Paeng, JC; Kim, YI; Kwon, HW; Cheon, GJ; Suh, KS; Kwon, CHD; Lee, DS; Kang, KW

EUR RADIOL 2019 10.1007/s00330-019-06128-5
Comparison of prognostic values of primary tumor and nodal F-18-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease
Lim1, CH; Hyun, SH; Moon, SH; Cho, YS; Choi, JY; Lee, KH

SCI REP-UK 2019 10.1038/s41598-019-48674-4
Predictive and Prognostic Value of F-18-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer
Moon1, SH; Sun, JM; Ahn, JS; Park, K; Kim, BT; Lee, KH; Ahn, MJ; Choi, JY

CURR CARDIOL REP 2019 10.1007/s11886-019-1193-x
Clinical Utility of [F-18]FDG-PET /CT in Pericardial Disease
Kim1, MS; Kim, EK; Choi, JY; Oh, JK; Chang, SA

EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04387-4
Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment
Kim1, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY

KOREAN J RADIOL 2019 10.3348/kjr.2018.0843
Diagnostic Performance of F-18-Fluorodeoxyglucose Positron Emission Tomography/CT for Chronic Empyema-Associated Malignancy
Cheon1, M; Yoo, J; Hyun, SH; Lee, KS; Kim, H; Kim, J; Zo, JI; Shim, YM; Choi, JY

MEDICINE 2019 10.1097/MD.0000000000016313
Evaluating the tumor biology of lung adenocarcinoma: A multimodal analysis
Kim1, KH; Ryu, SY; Lee, HY; Choi, JY; Kwon, OJ; Kim, HK; Shim, YM

EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04327-2
Prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma
Lim1, CH; Moon, SH; Cho, YS; Choi, JY; Lee, KH; Hyun, SH

Cancer Imaging 2019 10.1186/s40644-019-0225-5
Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography
Lee1, JY; Kim, YH; Park, YJ; Park, SB; Chung, HW; Zo, JI; Shim, YM; Lee, KS; Choi, JY

SCI REP-UK 2019 10.1038/s41598-019-43257-9
Synthesis and in vivo characterization of F-18-labeled difluoroboron-curcumin derivative for beta-amyloid plaque imaging
Kim1, H; Im, YH; Ahn, J; Yang, J; Choi, JY; Lee, KH; Kim, BT; Choe, YS

EUR RADIOL 2019 10.1007/s00330-018-5764-9
PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients
Lim1, CH; Ahn, TR; Moon, SH; Cho, YS; Choi, JY; Kim, BT; Lee, KH

CLIN RADIOL 2019 10.1016/j.crad.2018.12.010
Evaluation of a diagnostic F-18-FDG PET/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses
Lim1, CH; Seok, HY; Hyun, SH; Moon, SH; Cho, YS; Lee, KH; Kim, BT; Choi, JY

J THORAC IMAG 2019 10.1097/RTI.0000000000000390
Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer Improvements Using Radiomics
Lee1, G; Bak, SH; Lee, HY; Choi, JY; Park, H; Lee, SH; Ohno, Y; Nishino, M; van Beek, EJR; Lee, KS

ACS CHEM NEUROSCI 2019 10.1021/acschemneuro.8b00480
F-18-Labeled BODIPY Dye: A Potential Prosthetic Group for Brain Hybrid PET/Optical Imaging Agents
Kim1, H; Kim, K; Son, SH; Choi, JY; Lee, KH; Kim, BT; Byun, Y; Choe, YS

BREAST CANCER RES TR 2019 10.1007/s10549-018-5041-2
Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy
Kim1, YH; Hwang, JH; Bae, JH; Choi, JY

INT J CARDIOL 2019 10.1016/j.ijcard.2018.08.006
Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia
Choi1, KH; Lee, JM; Park, I; Kim, J; Rhee, TM; Hwang, D; Park, J; Park, TK; Yang, JH; Bin Song, Y; Hahn, JY; Jeong, DS; Cho, YH; Kim, WS; Sung, K; Jang, MJ; Sung, JD; Choi, JH; Choi, SH; Koo, BK; Lee, YT; Kim, EK; Chang, SA; Park, SJ; Choi, JO; Lee, SC; Park, SW; Cho, YS; Choi, JY; Gwon, HC; Oh, JK

EUR J NUCL MED MOL I 2019 10.1007/s00259-018-4138-5
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
Moon1, SH; Kim, J; Joung, JG; Cha, H; Park, WY; Ahn, JS; Ahn, MJ; Park, K; Choi, JY; Lee, KH; Kim, BT; Lee, SH

CLIN NUCL MED 2019 10.1097/RLU.0000000000002394
Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer FDG Uptake and Risk Stratification
Moon1, SH; Sun, JM; Ahn, JS; Park, K; Ahn, MJ; Choi, JY

J CLIN MED 2018 10.3390/jcm7120559
F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis
Choi1, JY; Jhun, BW; Hyun, SH; Chung, MJ; Koh, WJ

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002
Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles
Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH